How has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreNICE has decided to adapt the technical engagement step in a hope to improve stakeholder inclusion, ...
Read moreNICE has announced they will begin a phased restart of publishing guidance, whilst SMC meetings are ...
Read moreArrangements made between manufacturers and payers which are being implemented for innovative treatm...
Read moreNICE confirmed that they will be prioritising work that is therapeutically critical or relates to ad...
Read moreThe Westminster Health Forum organise senior level conferences on public policy relating to health a...
Read moreWith the UKs withdrawal from the European Union, NICE’s relationship with EMA and indeed, the para...
Read moreWhat are the pro’s and cons of seeking NICE approval using the Medical Technologies Evaluation Pro...
Read moreIn this study, we compared the use of financial agreements for oncology and non-oncology drugs asses...
Read moreIs the evidence base for high-cost CAR T-cell therapies Kymriah and Yescarta sufficient to be grante...
Read more